[1] R.L. Siegel, K.D. Miller, A.Jemal, Cancer statistics, 2018,CA Cancer J Clin. 68(1)(2018) 7–30.
[2] L.J. Wang, C.H. Yu, Z.Z. Zhang, H. Yan. Trend in lung cancer mortality among residents in China:1987-2014,J. Public Health of China. 33(1)(2017) 42-46.
[3] Surveillance, Epidemiology, and End Results Program. SEER cancer statistics review, 1975–2012,lung cancer. National Cancer Institute website.(2016).
[4] K. Imai, Y. Minamiya, H. Saito, S. Motoyama, Y. Sato, A. Ito.Diagnostic imaging in the preoperative management of lungcancer, Surg Today.44(7)(2014)1197–1206.
[5] P. Lu, Y. Sun. The role of 18F-FDG PET/CT for evaluation of metastatic mediastinal lymph nodes in patients with lung squamous-cell carcinoma or adenocarcinoma, Lung Cancer. 85(1)(2014) 53-58.
[6] O. Michielin, A.C.J. van Akkooi, P.A.Ascierto, R. Dummer, U. Keilholz. Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Ann Oncol. 30(12)(2019)1884-190.
[7] H. Wang,Q.K. Li, M. Auster, G. Gong. PET and CT features differentiating infectious/inflammatory from malignant mediastinal lymphadenopathy: A correlated study with endobronchial ultrasound-guided transbronchial needle aspiration,Radiol Infect Dis. 5(1)(2018)7-13.
[8] M. Sollini, F. Bandera, M.Kirienko. Quantitative imaging biomarkers in nuclear medicine: from SUV to image mining studies. Highlights from annals of nuclear medicine 2018, Eur J Nucl Med Mol Imaging.46(13)(2019)2737-2745.
[9]D. Divis, M.Barone, R.Crisc. Current role of standardized uptake valuemax-derived ratios in N2 fluorine-18 fluorodeoxyglucose positron-emission tomography non-small cell lung cancer, J.Thorac Dis. 10(1)( 2018)503-507.
[10] C. Zhou, J. Wang, H. Bu. Chinese Experts Consensus on Immune Checkpoint Inhibitors for Non-small Cell Lung Cancer (2019 version), Chinese journal of lung cancer, 23(2)(2020)65-76.
[11] J. Cha,S. Kim, J. Wang. Evaluation of 18F-FDG PET/CT Parameters for Detection of Lymph Node Metastasis in Cutaneous Melanoma,Nucl Med Mol Imaging, 52(1)(2017)39-45.
[12] J.W. Lee, E.Y. Kim, D.J. Kim. The diagnostic ability of (18)F-FDG PET/CT for mediastinal lymph node staging using (18)F-FDG uptake and volumetric CT histogram analysis in non-small cell lung cancer, European Radiology. 26(12)(2016) 1-9.
[13] E. Wolsztynski, J. O'Sullivan, N.M. Hughes, T. Mou, P. Murphy, F. O'Sullivan,K. O'Regan.Combining structural and textural assessments of volumetric FDG-PET uptake in NSCLC. IEEE Trans Radiat Plasma Med Sci, 3(4)(2019)421-433.
[14] C.H. Lim, S.H. Hyun,S.H. Moon, Y.S. Cho, J.Y. Choi, K.H. Lee. Comparison of prognostic values of primary tumor and nodal 18F-fluorodeoxyglucose uptake in non-small cell lung cancer with N1 disease.EurRadiol, 29(10)( 2019) 5288-5297.
[15] X. Zhai, Y. Guo, X. Qian. Combination of Fluorine-18 Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography (¹⁸F-FDG PET/CT) and Tumor Markers to Diagnose Lymph Node Metastasis in Non-Small Cell Lung Cancer (NSCLC): A Retrospective and Prospective Study, Med SciMonit. 2020 2(26)(2020)e922675.
[16] A.D. Trister, D.A. Pryma, E. Xanthopoulos, J. Kucharczuk, D. Sterman, R.Rengan. Prognostic value of primary tumor FDG uptake for occult mediastinal lymph node involvement in clinically N2/N3 node-negative non-small cell lung cancer, Am J ClinOncol. 37(2)(2014)135-139.
[17] F.U. Chowdhury, F. Sheerin, K.M. Bradley.Sarcoid-like reaction to malignancy on whole-body integrated (18)F-FDG PET/CT: prevalence and disease pattern,Clin. Radiol. 64(7)(2009)675–681.
[18] E.J Chun, H.J. Lee, W. J. Kang. Differentiation between malignancy and inflammation in pulmonary ground-glass nodules: the feasibility of integrated (18)F-FDG PET/CT, Lung Cancer. 65(2)(2009): 180–186.
[19] X.C. Li,L.Q. Miao, J. Qian. Accuracy of PET/CT in the diagnosis of mediastinal lymph node staging of non-small cell lung cancer - Mata analysis, Chinese Journal of Medical Imaging. 22 (7)(2014) 540-546.
[20] F. Moloney,F. Ryan,L. McCarthy, L. Burke,M.T. Henry, M.P. Kennedy, J. Hinchion, S. McSweeney, M.M. Maher, K. O'Regan. Increasing the accuracy of 18F-FDG PET/CT interpretation of "mildly positive" mediastinal nodes in the staging of non-small cell lung cancer,Eur J Radiol. 83(5)(2014)843-847.